Clinical Trials Sponsored by Syntactx

Total 36 results

Withings
Syntactx

Completed

Withings ECG-app Study

Atrial Fibrillation

United States, France
Withings
Syntactx

Completed

Withings ECG-Monitor Study

Atrial Fibrillation

United States, France
Renaissance RX
Syntactx

Unknown

Diagnosing Adverse Drug Reactions Registry (DART)

Genetics of Drug Metabolism

United States
Renaissance RX
Syntactx

Withdrawn

Urine Toxicology With Pharmacogenomic Interpretation Assay: UTOPIA (UTOPIA)

Urine Toxicology
Molnlycke Health Care AB
Syntactx

Completed

Confirm Safety and Performance of Avance Solo and Avance Solo Adapt NPWT Systems (ASOLO-CW)

Diabetic Foot Ulcer | Venous Leg Ulcer | Pressure Ulcer | Chronic Ulcer

France, Belgium, Germany, Ireland, Italy, Denmark, Portugal
Rex Medical
Syntactx

Completed

Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization (REVEAL)

Peripheral Artery Disease

United States
InSource Diagnostics
Syntactx

Unknown

Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens (SPHERE)

Target Drug-related Adverse Events

United States
Lungpacer Medical Inc.
Syntactx

Completed

Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE2)

Ventilator Induced Diaphragm Dysfunction

Germany, France
General Genetics Corporation
Syntactx

Unknown

Pharmacogenomic Testing Of the Elderly To Reduce Morbidity (POETRY)

Genetics of Drug Metabolism

United States, Puerto Rico
BlackSwan Vascular, Inc.
Syntactx

Completed

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

Peripheral Arterial Hemorrhage

United States
Lungpacer Medical Inc.
Syntactx

Completed

Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1) (RESCUE1)

Ventilator Induced Diaphragm Dysfunction

United States
Lake Washington Vascular
Syntactx

Completed

Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES) (WAVES)

Venous Reflux

United States
Molnlycke Health Care AB
Syntactx

Not yet recruiting

A Safety and Performance PMCF Investigation of the Avance® Solo NPWT System in Surgically Closed Incisions (ASOLO-SCI)

Surgical Wound | Surgical Incision | Surgical Wound Dehiscence | Incision, Surgical | Surgical Wound, Recent
Endologix
PQ Bypass, Inc.; Syntactx

Active, not recruiting

TORUS 2 IDE Clinical Study

Peripheral Arterial Disease

United States
Molnlycke Health Care AB
Syntactx

Completed

Confirm the Safety and Performance of Avance Solo NPWT System (ASOLO-SW)

Acute Wound | Skin Graft | Skin Flap | Traumatic Wound | Dehiscence | Subacute Wound

Belgium, Italy, Germany, France
MiCo BioMed Co., Ltd.
Syntactx

Completed

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

SARS-CoV2 Infection

United States
Outpatient Endovascular and Interventional Society
Syntactx

Recruiting

OEIS Outcome Data Registry

Peripheral Arterial Disease

United States
Philippe Cuypers
Syntactx

Completed

ZEnith AlPHa for AneurYsm Repair (ZEPHYR)

Aneurysm

Germany, Belgium, Netherlands
Elixir Medical Corporation
Massachusetts General Hospital; Syntactx; Genae

Completed

The DESappear Study: Drug Eluting Scaffold (DESappear)

Peripheral Vascular Disease

New Zealand, Austria, Germany, Belgium
SynAct Pharma Aps

Completed

A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease (SynAct-CS002)

Rheumatoid Arthritis

Denmark, Norway
Hancock Jaffe Laboratiores, Inc
Syntactx; AXIOM Real Time Metrics

Recruiting

The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

Deep Venous Insufficiency (Diagnosis)

United States
SynAct Pharma Aps

Recruiting

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy | Severe Proteinuria Due to Idiopathic Membranous Nephropathy

Denmark
Fundación de investigación HM
Syntax for Science, S.L

Recruiting

A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours

Neuroendocrine Tumours (NET) | Neuroendocrine Carcinomas (NEC)

Spain
Fundación de investigación HM
Syntax for Science, S.L

Active, not recruiting

Nalirinox Neo-pancreas RAS Mut ctDNA Study

Resectable Pancreatic Ductal Adenocarcinoma

Spain
SynAct Pharma Aps
NBCD A/S

Completed

A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment (EXPAND)

Rheumatoid Arthritis

Moldova, Republic of
SynAct Pharma Aps
NBCD A/S

Recruiting

A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (RESOLVE)

Rheumatoid Arthritis

Moldova, Republic of
Medtronic Spinal and Biologics
Medical College of Wisconsin; Syntactx; Exponent, Inc.; Medical Metrics Diagnostics...

Active, not recruiting

Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis (BRAIVE IDE)

Adolescent Idiopathic Scoliosis | Juvenile Idiopathic Scoliosis

United States, Canada, United Kingdom
Fundación de investigación HM
Syntax for Science, S.L

Completed

A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Locally Advanced Rectal Cancer (LARC)

Spain
Fundación de investigación HM
Syntax for Science, S.L

Completed

Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage (EarlyFocus)

Parkinson Disease

Spain
Fundación de investigación HM
Syntax for Science, S.L

Terminated

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Covid-19

Spain
LiNA Medical
Syntactx; West Virginia University, Pathology Laboratory for Translational... and other collaborators

Unknown

Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss (LEADER)

Menorrhagia | Heavy Menstrual Bleeding
Spanish Oncology Genito-Urinary Group
Ipsen; Syntax for Science, S.L

Completed

Spanish Real-World Evidence Cabozantinib (SRWEC)

Renal Cell Carcinoma

Spain
Spanish Oncology Genito-Urinary Group
Bristol-Myers Squibb; Syntax for Science, S.L

Active, not recruiting

A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

Metastatic Hormone-sensitive Prostate Cancer

Spain
PETHEMA Foundation
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Syntax for Science, S.L

Active, not recruiting

A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment

Acute Myeloid Leukemia

Spain
Instituto Valenciano de Infertilidad, IVI Alicante
Fundación IVI; Syntax for Science, S.L; Merck, S.L., Spain

Recruiting

Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH) (PRE-LH)

Infertility, Female

Spain
Banc de Sang i Teixits
Syntax for Science, S.L; Hospital de Neurorehabilitació Institut Guttmann; Recerca...

Completed

Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury

Spinal Cord Injury, Chronic

Spain

Clinical Trials Sponsored by Syntactx

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations